| 发明名称 |
METHOD OF TREATMENT |
| 摘要 |
The present invention relates to methods of treating subjects having heart failure with preserved ejection fraction (HFpEF) with a sustained-delivery formulation of cardiotonic 5-(pyridinyl)-2(1H)-pyridinone compounds. |
| 申请公布号 |
WO2016101024(A1) |
申请公布日期 |
2016.06.30 |
| 申请号 |
WO2015AU50820 |
申请日期 |
2015.12.21 |
| 申请人 |
BAKER IDI HEART & DIABETES INSTITUTE HOLDINGS LIMITED |
发明人 |
KAYE, DAVID |
| 分类号 |
A61K31/444;A61K9/22;A61P9/04 |
主分类号 |
A61K31/444 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
